All In Biotech

Drug Trial Radar · NCT06799637

Study of XNW28012 in Subjects With Advanced Solid Tumors Who Failed Standard Treatments

A Phase 1, Open-Label, Multicenter Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Antitumor Efficacy of XNW28012 in Subjects With Advanced Solid Tumors

Last checked: Nov 19, 2026Latest source record: Apr 15, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

350

Planned (sponsor's estimate)

Start

Dec 1, 2023

Primary completion

Dec 31, 2026

Study completion Dec 31, 2026

Sponsor

Lead sponsor
Evopoint Biosciences Inc.Industry
Sponsor type
Industry
First posted
Jan 29, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1 / Phase 2
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is an open-label, dose escalation, multicenter, phase 1, first-in-human study of XNW28012 in subjects with advanced solid tumors who have failed current standard anti-tumor therapies or are intolerant to such therapies. The study consists of two parts: a dose escalation part and a dose expansion part.

Conditions

  • Advanced Solid Tumors
  • Pancreatic Carcinoma
  • Ovarian Cancer
  • Cervical Cancers

Interventions

  • XNW28012Drug

    Eligible subjects will receive XNW28012 every 3 weeks (Q3W) until intolerant toxicity, progression of disease with no clinical benefit, or withdrawal of informed consent.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Ph 1: Incidence and severity of treatment-emergent adverse events (AEs) [Safety and Tolerability].Time frame: through study completion, an average of 1 year
  2. Ph 2: To evaluate the antitumor efficacy of XNW28012 at the recommended Part 2 dose.Time frame: through study completion, an average of 1 year

Locations

24 sites in 1 country. Site status is shown where the registry gives one.

  • Second Affiliated Hospital of Anhui Medical University

    Hefei, Anhui, China · Recruiting

  • The First Affiliated Hospital of University of Science and Technology of China

    Hefei, Anhui, China · Recruiting

  • Beijing Friendship Hospital, Capital Medical University

    Beijing, Beijing Municipality, China · Recruiting

  • Peking Union Medical College Hospital

    Beijing, Beijing Municipality, China · Recruiting

  • Chongqing University Cancer Hospital

    Chongqing, Chongqing Municipality, China · Recruiting

  • Fujian Provincial Cancer Hospital

    Fuzhou, Fujian, China · Recruiting

  • Sun Yat-sen Memorial Hospital, Sun Yat-sen University

    Guangzhou, Guangdong, China · Recruiting

  • Affiliated Hospital of Guizhou Medical University

    Guiyang, Guizhou, China · Recruiting

  • Affiliated Hospital of Hebei University

    Baoding, Hebei, China · Recruiting

  • Affiliated Cancer Hospital of Harbin Medical University

    Harbin, Heilongjiang, China · Recruiting

  • First Affiliated Hospital of Henan University of Science and Technology

    Luoyang, Henan, China · Recruiting

  • Hubei Cancer Hospital

    Wuhan, Hubei, China · Recruiting

  • Hunan Cancer Hospital

    Changsha, Hunan, China · Recruiting

  • The Second Xiangya Hospital Of Central South University

    Changsha, Hunan, China · Recruiting

  • First Affiliated Hospital of Gannan Medical College

    Ganzhou, Jiangxi, China · Recruiting

  • First Affiliated Hospital of Kunming Medical University

    Yunnan, Kunming, China · Recruiting

  • Affiliated Hospital of Binzhou Medical College

    Binzhou, Shandong, China · Recruiting

  • Jinan Central Hospital

    Jinan, Shandong, China · Recruiting

  • Linyi Cancer Hospital

    Linyi, Shandong, China · Recruiting

  • Fudan University Shanghai Cancer Center

    Shanghai, Shanghai Municipality, China · Recruiting

  • Sichuan Provincial People's Hospital

    Chengdu, Sichuan, China · Recruiting

  • West China Hospital of Sichuan University

    Chengdu, Sichuan, China · Recruiting

  • Yunnan Cancer Hospital

    Kunming, Yunnan, China · Recruiting

  • The First Affiliated Hospital of Zhejiang University School of Medicine

    Hangzhou, Zhejiang, China · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.